Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity

    January 2010 in “ Mediators of Inflammation
    Thozhukat Sathyapalan, Stephen L. Atkin
    TLDR PCOS is linked to obesity and inflammation, increasing cardiovascular risk.
    The document discussed the relationship between polycystic ovary syndrome (PCOS), obesity, and inflammation. PCOS was a common endocrine disorder in women, often associated with obesity, insulin resistance, and increased cardiovascular risk. Obesity in PCOS was linked to chronic systemic inflammation, with elevated levels of inflammatory markers such as TNF α, IL-6, and hs-CRP. These inflammatory processes were thought to contribute to insulin resistance and cardiovascular disease. The study highlighted that both obese and normoweight women with PCOS exhibited altered fat distribution, particularly increased visceral fat, which was associated with increased cardiovascular risk. The findings suggested that chronic low-grade inflammation and adipocyte dysfunction might be novel mechanisms contributing to the heightened cardiovascular risk in women with PCOS.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 21 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 7 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community C’est terrible - at my wits end

      in Female  450 upvotes 2 years ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Similar Research

    5 / 1000+ results